SCHEMBL1689698

SCHEMBL1689698

OC/C=C(\Cl)c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAPK1 P28482 2/20 0.44
CYP3A4 P08684 1/20 0.44
ATM Q13315 1/20 0.44
CES2 O00748 2/20 0.41
CES1 P23141 2/20 0.41
GSK3B P49841 2/20 0.40
BCL2L1 Q07817 1/20 0.40
ALOX15 P16050 1/20 0.39
LMNA P02545 3/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CYP2A6 P11509 1/20 0.36
SRD5A2 P31213 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1689702 1.00 TSHR (0.44) TSHRL3MBTL1MAPK1CYP3A4ATM
SCHEMBL1689701 1.00 TSHR (0.44) TSHRL3MBTL1MAPK1CYP3A4ATM
SCHEMBL1689616 0.82 GSK3B (0.45) TSHRL3MBTL1MAPK1CYP3A4ATM
SCHEMBL10904510 0.82 GSK3B (0.45) TSHRL3MBTL1MAPK1CYP3A4ATM
SCHEMBL1689613 0.82 GSK3B (0.45) TSHRL3MBTL1MAPK1CYP3A4ATM
SCHEMBL9618279 0.80 TSHR (0.43) TSHRL3MBTL1MAPK1CYP3A4ATM
SCHEMBL4631460 0.79 KMT2A (0.42) TSHRMAPK1CYP3A4ATMCES2
SCHEMBL9052487 0.79 BCL2L1 (0.55) TSHRL3MBTL1MAPK1CYP3A4ATM
SCHEMBL4631463 0.79 KMT2A (0.42) TSHRMAPK1CYP3A4ATMCES2
SCHEMBL1689646 0.77 CES2 (0.41) TSHRL3MBTL1MAPK1CYP3A4ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515969-B2 SPIROINDOLINEPIPERIDINE DERIVATIVES SYNGENTA LTD (GB) 2017-10-11 EP disclosed
US-9686990-B2 Spiroindolinepiperidine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2017-06-27 US disclosed
US-20160007608-A1 SPIROINDOLINEPIPERIDINE DERIVATIVES SYNGENTA LIMITED (GB) 2016-01-14 US disclosed
US-9174987-B2 Spiroindolinepiperidine derivatives SYNGENTA LIMITED (DE) 2015-11-03 US disclosed
EP-1880996-B1 SPIROINDOLINEPIPERIDINE DERIVATIVES SYNGENTA LTD (GB) 2014-12-24 EP disclosed
US-20120010220-A1 SPIROINDOLINEPIPERIDINE DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2012-01-12 US disclosed
EP-1515969-B1 SPIROINDOLINEPIPERIDINE DERIVATIVES SYNGENTA LTD (GB) 2010-08-25 EP disclosed
EP-1880996-A1 Spiroindolinepiperidine derivatives Syngenta Limited (GB) 2008-01-23 EP disclosed
US-20060106045-A1 Spiroindolinepiperidine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2006-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010220-A1 SPIROINDOLINEPIPERIDINE DERIVATIVES RECQL, OPRD1, SKP1 TSHR 2704/4885L3MBTL1 2180/4885MAPK1 2842/4885
US-20060106045-A1 Spiroindolinepiperidine derivatives RECQL, OPRD1, NCAPD3 TSHR 2644/4885L3MBTL1 2022/4885MAPK1 2856/4885
US-20160007608-A1 SPIROINDOLINEPIPERIDINE DERIVATIVES RECQL, OPRD1, SKP1 TSHR 2704/4885L3MBTL1 2180/4885MAPK1 2842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.